VSee Health (NASDAQ:VSEE – Get Free Report) was upgraded by equities research analysts at Wall Street Zen to a “sell” rating in a research report issued to clients and investors on Saturday.
Separately, Weiss Ratings restated a “sell (e+)” rating on shares of VSee Health in a research note on Wednesday, October 8th. One research analyst has rated the stock with a Strong Buy rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $5.00.
Check Out Our Latest Report on VSEE
VSee Health Price Performance
VSee Health (NASDAQ:VSEE – Get Free Report) last issued its earnings results on Friday, November 14th. The company reported ($0.02) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.08) by $0.06. The company had revenue of $3.98 million for the quarter, compared to analysts’ expectations of $4.10 million. VSee Health had a negative net margin of 69.80% and a negative return on equity of 131.02%.
Institutional Inflows and Outflows
Several institutional investors have recently added to or reduced their stakes in the business. XTX Topco Ltd purchased a new position in shares of VSee Health during the 1st quarter worth $34,000. Osaic Holdings Inc. raised its holdings in VSee Health by 197.5% in the 2nd quarter. Osaic Holdings Inc. now owns 45,170 shares of the company’s stock worth $52,000 after purchasing an additional 29,985 shares during the period. Finally, HB Wealth Management LLC bought a new position in VSee Health in the 3rd quarter worth $368,000. 1.01% of the stock is currently owned by institutional investors.
VSee Health Company Profile
VSee Health, Inc is a no-code or low-code software as a service (SaaS) platform that enables clinicians and enterprises to create their telehealth workflows without programming. It engages in providing timely, quality healthcare to patients regardless of geographical barriers. The company is headquartered in Boca Raton, FL.
Read More
- Five stocks we like better than VSee Health
- Top Biotech Stocks: Exploring Innovation Opportunities
- Rocket Lab’s Big Rebound? Analysts Suggest the Dip’s a Gift
- How to Invest in Small Cap Stocks
- Meta’s AI Moment? New SAM 3 Model Has Wall Street Turning Bullish
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Snowflake Stock: The Dip That Smart Investors Are Buying Right Now
Receive News & Ratings for VSee Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VSee Health and related companies with MarketBeat.com's FREE daily email newsletter.
